Context Clopidogrel therapy improves cardiovascular outcomes in patients with acute coronary
syndromes and following percutaneous coronary intervention by inhibiting adenosine …

Apolipoprotein C-III (apoC-III) inhibits triglyceride hydrolysis and has been implicated in
coronary artery disease. Through a genome-wide association study, we have found that about 5…

Background The β 3 -adrenergic receptor is expressed in visceral adipose tissue and is
thought to contribute to the regulation of the resting metabolic rate and lipolysis. Methods To …

To extend understanding of the genetic architecture and molecular basis of type 2 diabetes (T2D),
we conducted a meta-analysis of genetic variants on the Metabochip, including …

To identify genetic variants influencing plasma lipid concentrations, we first used genotype
imputation and meta-analysis to combine three genome-wide scans totaling 8,816 individuals …

Background Because visceral obesity predicts insulin resistance, we studied whether alterations
in the gene encoding for the β 3 -adrenergic receptor in visceral fat are associated with …

A major goal in human genetics is to use natural variation to understand the phenotypic
consequences of altering each protein-coding gene in the genome. Here we used exome …

ContextIndividuals with exceptional longevity have a lower incidence and/or significant delay
in the onset of age-related disease, and their family members may inherit biological factors …

Central (visceral) obesity is more closely associated with insulin resistance, type 2 diabetes,
and cardiovascular disease than is peripheral [subcutaneous (sc)] obesity, but the …

Central obesity and the accumulation of visceral fat are risk factors for the development of type
2 diabetes and cardiovascular disease. Omentin is a protein expressed and secreted from …